23. Gilboa S.M., Strickland M.J., Olshan A.F., Werler M.M., Correa A., National Birth Defects Prevention Study Use of antihistamine medications during early pregnancy and isolated major malformations // Birth Defects Res A Clin Mol Teratol. 2009. Vol. 85, № 2. P. 137-50.
24. Diav-Citrin O., Shechtman S., Aharonovich A., Moerman L., Arnon J., Wajnberg R., et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled study // J Allergy Clin Immunol. 2003.
Vol. 111. P. 1239-43.
25. Centers for Disease Control and Prevention (CDC). Evaluation of an association between loratadine and hypospadias United States, 1997-2001 // MMWR Morb Mortal Wkly Rep. 2004. Vol. 53. P. 219-221.
26. Källén B. Use of antihistamine drugs in early pregnancy and delivery outcome // J Matern Fetal Neonatal Med. 2002. Vol. 11, № 3. P. 146-152.
27. Diav-Citrin O., Shechtman S., Aharonovich A., Moerman L., Arnon J., Wajnberg R., et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled study // J Allergy Clin Immunol. 2003.
Vol. 111, № 6. P. 1239-1243.
28. NAEPP Report of the Working Group on Asthma and Pregnancy: Management of Asthma During Pregnancy. NIH Publication No. 93-3279. Bethesda, MD: U.S. Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; 1993. [Accessed May 11, 2011]. Asthma and Pregnancy Report.
29. Rindi V. La eliminazione degli antistaminici di sintesi con il latte e l'azione latto-goga de questi // Riv Ital Ginecol. 1951. Vol. 34. P. 147-157.
30. Findlay J.W., Butz R.F., Sailstad J.M., Warren J.T., Welch R.M. Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers // Br J Clin Pharmacol. 1984. Vol. 18, № 6. P. 901-906.